oxprenolol has been researched along with Cardiovascular Pregnancy Complications in 20 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One hundred pregnant women with hypertension (defined as diastolic blood pressure at or above 95 mm Hg) were allocated at random to treatment with methyldopa or oxprenolol and were compared with nonhypertensive controls matched according to parity and gestation at delivery." | 9.05 | Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. ( De Swiet, M; Fayers, P; Fidler, J; Smith, V, 1983) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 9.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| "Fifty-three pregnant women with moderately severe hypertension were randomly allocated to treatment with methyldopa or oxprenolol." | 9.04 | Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. ( Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM, 1979) |
| "The combination of prazosin (3-21 mg/day) and oxprenolol (60-360 mg/day) was used to treat 25 pregnant women with severe essential hypertension and 19 women with the hypertension-oedema-proteinuria syndrome." | 7.66 | Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. ( Hodge, JV; Lubbe, WF, 1981) |
| "Prazosin (Minipress; Pfizer), the first purely alpha-blocking antihypertensive agent, was used to treat 22 pregnant patients with moderately severe hypertension (diastolic blood pressure persistently above 95 mmHg at gestational ages ranging from 18 to 33 weeks)." | 7.66 | Prazosin and oxprenolol therapy in pregnancy hypertension. ( Davey, DA; Dommisse, J; Roos, PJ, 1983) |
| "One hundred pregnant women with hypertension (defined as diastolic blood pressure at or above 95 mm Hg) were allocated at random to treatment with methyldopa or oxprenolol and were compared with nonhypertensive controls matched according to parity and gestation at delivery." | 5.05 | Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy. ( De Swiet, M; Fayers, P; Fidler, J; Smith, V, 1983) |
| " Control of hypertension was equivalent in both treatment groups, and in 64 (35%) cases hydralazine had to be added to the treatment to achieve the therapeutic goal (diastolic blood pressure below 85 mm Hg)." | 5.05 | Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. ( Gallery, ED; Gyory, AZ; Ross, MR, 1985) |
| "Fifty-three pregnant women with moderately severe hypertension were randomly allocated to treatment with methyldopa or oxprenolol." | 5.04 | Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. ( Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM, 1979) |
| "The combination of prazosin (3-21 mg/day) and oxprenolol (60-360 mg/day) was used to treat 25 pregnant women with severe essential hypertension and 19 women with the hypertension-oedema-proteinuria syndrome." | 3.66 | Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. ( Hodge, JV; Lubbe, WF, 1981) |
| "Prazosin (Minipress; Pfizer), the first purely alpha-blocking antihypertensive agent, was used to treat 22 pregnant patients with moderately severe hypertension (diastolic blood pressure persistently above 95 mmHg at gestational ages ranging from 18 to 33 weeks)." | 3.66 | Prazosin and oxprenolol therapy in pregnancy hypertension. ( Davey, DA; Dommisse, J; Roos, PJ, 1983) |
| " Reversal of this intrauterine growth retardation was achieved in 19 patients by treatment of hypertension with oxprenolol." | 3.66 | Improvement in foetal growth with treatment of maternal hypertension in pregnancy. ( Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (95.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lubbe, WF | 3 |
| Hodge, JV | 2 |
| Sandström, B | 1 |
| Rubin, PC | 1 |
| Fidler, J | 1 |
| Smith, V | 1 |
| Fayers, P | 1 |
| De Swiet, M | 1 |
| Sioufi, A | 1 |
| Hillion, D | 1 |
| Lumbroso, P | 1 |
| Wainer, R | 1 |
| Olivier-Martin, M | 1 |
| Schoeller, JP | 1 |
| Colussi, D | 1 |
| Leroux, F | 1 |
| Mangoni, P | 1 |
| Gallery, ED | 5 |
| Dommisse, J | 1 |
| Davey, DA | 1 |
| Roos, PJ | 1 |
| Kellaway, GS | 1 |
| Smith, GL | 1 |
| Larkin, H | 1 |
| Hunyor, SN | 3 |
| Gyory, AZ | 4 |
| Boyce, ES | 1 |
| Monnier, JC | 1 |
| Honore, P | 1 |
| Lanciaux, B | 1 |
| Boulogne, M | 1 |
| Saunders, DM | 2 |
| Nysenbaum, A | 1 |
| McFarlane, T | 1 |
| Gadd, RL | 1 |
| Plouin, PF | 1 |
| Breart, G | 1 |
| Llado, J | 1 |
| Dalle, M | 1 |
| Keller, ME | 1 |
| Goujon, H | 1 |
| Berchel, C | 1 |
| Fogari, R | 1 |
| Zoppi, A | 1 |
| Kawecka-Jaszcz, K | 1 |
| Skoczeń, M | 1 |
| Ross, MR | 1 |
| Collins, R | 1 |
| Chalmers, I | 1 |
| Peto, R | 1 |
3 reviews available for oxprenolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Pregnancy-associated hypertension: interrelationships of volume and blood pressure changes.
Topics: Blood Pressure; Blood Volume; Extracellular Space; Female; Humans; Hypertension; Oxprenolol; Plasma | 1982 |
[Beta-blockers in the therapy of arterial hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Diuretics; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Pre-Ec | 1985 |
[Beta-blockaders in the treatment of hypertension in pregnancy].
Topics: Adrenergic beta-Antagonists; Atenolol; Drug Evaluation; Female; Humans; Hypertension; Metoprolol; Ox | 1985 |
5 trials available for oxprenolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Gestational Age; Humans; Hypertension; Methyl | 1983 |
Cardiac and haemodynamic measurements in hypertensive pregnancy.
Topics: Adult; Cardiac Output; Echocardiography; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hype | 1980 |
Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Blood Glucose; Creatinine; Female; Humans; Hypertension; Methyldopa; Oxprenolol | 1979 |
A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension.
Topics: Adult; Birth Weight; Cesarean Section; Dihydralazine; Double-Blind Method; Drug Therapy, Combination | 1990 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Ne | 1985 |
12 other studies available for oxprenolol and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Drug Therapy, Combination | 1981 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growt | 1984 |
Beta blockers in pregnancy.
Topics: Adrenergic beta-Antagonists; Atenolol; Female; Humans; Hypertension; Kinetics; Methyldopa; Oxprenolo | 1984 |
Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk.
Topics: Adolescent; Adult; Female; Humans; Hypertension; Infant, Newborn; Maternal-Fetal Exchange; Milk, Hum | 1984 |
Prazosin and oxprenolol therapy in pregnancy hypertension.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Oxprenolol; Prazosin; Pregn | 1983 |
Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80.
Topics: Antihypertensive Agents; Bed Rest; Benzothiadiazines; Birth Weight; Diuretics; Drug Therapy, Combina | 1982 |
Oxprenolol in pregnancy.
Topics: Female; Humans; Hypertension; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1980 |
The management of hypertension in pregnancy.
Topics: Adult; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hypertension; Oxprenolol; Prazosin; | 1981 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; H | 1978 |
Improvement in foetal growth with treatment of maternal hypertension in pregnancy.
Topics: Birth Weight; Female; Humans; Hypertension; Infant, Newborn; Oxprenolol; Pregnancy; Pregnancy Compli | 1978 |
Fetal hazards of altering hypotensive regimens in pregnancy.
Topics: Adult; Female; Fetal Distress; Humans; Hypertension; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Co | 1979 |
Antihypertensive treatment in pregnancy.
Topics: Female; Humans; Hypertension; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular | 1985 |